Choreo, LLC Collegium Pharmaceutical, Inc Transaction History
Choreo, LLC
- $7.23 Billion
- Q2 2025
A detailed history of Choreo, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Choreo, LLC holds 11,367 shares of COLL stock, worth $396,139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,367
Previous 11,408
0.36%
Holding current value
$396,139
Previous $340,000
1.18%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding COLL
# of Institutions
238Shares Held
35.9MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$202 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$110 Million2.15% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$92.1 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$78.4 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.58MShares$55.2 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.19B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...